$190,000 of TELADOC HEALTH INC. lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"H.R.4206/S. 1261 - CONNECT for Health Act of 2025; all provisions of the bill"
You can find more data on corporate lobbying on Quiver Quantitative.
TDOC Insider Trading Activity
TDOC insiders have traded $TDOC stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $TDOC stock by insiders over the last 6 months:
- MALA MURTHY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 2 sales selling 26,702 shares for an estimated $192,489.
- CHARLES III DIVITA (CHIEF EXECUTIVE OFFICER) sold 16,787 shares for an estimated $127,435
- FERNANDO M. RODRIGUES (President of BetterHelp) has made 0 purchases and 4 sales selling 13,064 shares for an estimated $94,584.
- ADAM C VANDERVOORT (CHIEF LEGAL OFFICER, SECRETARY) has made 0 purchases and 2 sales selling 11,675 shares for an estimated $84,344.
- KELLY BLISS (President, U.S. Group Health) has made 0 purchases and 2 sales selling 9,353 shares for an estimated $67,569.
- CARLOS NUENO (President, International) has made 0 purchases and 2 sales selling 7,956 shares for an estimated $57,476.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
TDOC Hedge Fund Activity
We have seen 154 institutional investors add shares of TDOC stock to their portfolio, and 181 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WOODLINE PARTNERS LP added 1,560,442 shares (+inf%) to their portfolio in Q2 2025, for an estimated $13,591,449
- POINT72 ASSET MANAGEMENT, L.P. added 1,329,852 shares (+20.4%) to their portfolio in Q2 2025, for an estimated $11,583,010
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 1,292,854 shares (+171.6%) to their portfolio in Q2 2025, for an estimated $11,260,758
- VANGUARD GROUP INC added 1,266,880 shares (+6.4%) to their portfolio in Q2 2025, for an estimated $11,034,524
- BLACKROCK, INC. removed 1,139,371 shares (-7.6%) from their portfolio in Q2 2025, for an estimated $9,923,921
- JPMORGAN CHASE & CO removed 1,039,562 shares (-81.3%) from their portfolio in Q2 2025, for an estimated $9,054,585
- BRIDGEWAY CAPITAL MANAGEMENT, LLC added 1,002,189 shares (+inf%) to their portfolio in Q2 2025, for an estimated $8,729,066
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
TDOC Analyst Ratings
Wall Street analysts have issued reports on $TDOC in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 05/01/2025
- Goldman Sachs issued a "Buy" rating on 05/01/2025
To track analyst ratings and price targets for TDOC, check out Quiver Quantitative's $TDOC forecast page.
TDOC Price Targets
Multiple analysts have issued price targets for $TDOC recently. We have seen 10 analysts offer price targets for $TDOC in the last 6 months, with a median target of $8.875.
Here are some recent targets:
- Elizabeth Anderson from Evercore ISI Group set a target price of $9.0 on 10/08/2025
- Steven Valiquette from Mizuho set a target price of $10.0 on 07/25/2025
- Allen Lutz from B of A Securities set a target price of $7.0 on 05/28/2025
- Jailendra Singh from Truist Securities set a target price of $9.0 on 05/27/2025
- Stan Berenshteyn from Wells Fargo set a target price of $8.0 on 05/08/2025
- Richard Close from Canaccord Genuity set a target price of $12.0 on 05/01/2025
- David Roman from Goldman Sachs set a target price of $10.0 on 05/01/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
